Over 15 years of expertise in designing, expressing, purifying, and characterizing recombinant proteins, spanning cytosolic, nuclear, membrane, and secreted protein domains. Holds a PhD in Biology, with 5 years of postdoctoral research and 9 years of industry experience. Specialized in designing and cloning recombinant proteins with enhanced features, along with developing and executing strategies for protein expression and multistep purification processes. Proven leadership in guiding small teams of research associates and collaborating effectively with other teams. Author of 8 peer-reviewed articles published in high-impact journals, including Nature, Neuron, and the Journal of Cell Science. Holder of 2 granted patents, with one successfully launched product in the market.
sCD38, soluble recombinant human CD38 that neutralizes therapeutic anti-CD38 as Daratumumab present in the patient's plasma and eliminates its interferences with routine pre-transfusion testing., https://www.diagnostic.grifols.com/documents/4804410/4807854/Brochure_Grifols_sCD381.pdf/268182d2b29c-b550-6d33-ade04acf4933?t=1698793524337